RUBICON — Rubicon Research Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual income statement for Rubicon Research, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,136	3,935	8,539	12,843	17,540
Cost of Revenue
Gross Profit	2,353	2,803	5,748	9,089	11,979
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,867	4,111	7,377	10,649	13,990
Operating Profit	-731	-176	1,162	2,194	3,550
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-661	-110	1,029	1,945	3,205
Provision for Income Taxes
Net Income After Taxes	-671	-169	910	1,344	2,467
Net Income Before Extraordinary Items
Net Income	-671	-169	910	1,344	2,467
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-671	-169	910	1,344	2,467
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.37	-0.408	7.21	10.9	15.3
Dividends per Share